Table 3 Net reclassification improvement analyses between EB and BN2 based on BSI groups
EB | BN2 | |||||
|---|---|---|---|---|---|---|
<0.1 | 0.1 to 1 | 1 to 5 | >5 | Total | ||
Metastasis (n = 169): net gain in reclassification proportion = −40.8%, p < 0.0001 | <0.1 | 3 | 0 | 0 | 0 | 3 |
1.8% | 0.0% | 0.0% | 0.0% | |||
0.1 to 1 | 6 | 28 | 0 | 0 | 34 | |
3.6% | 16.6% | 0.0% | 0.0% | |||
1 to 5 | 4 | 48 | 40 | 0 | 92 | |
2.4% | 28.4% | 23.7% | 0.0% | |||
>5 | 0 | 1 | 10 | 29 | 40 | |
0.0% | 0.6% | 5.9% | 17.2% | |||
Total | 13 | 77 | 50 | 29 | 169 | |
No metastasis (n = 334) net gain in reclassification proportion = −72.8%, p < 0.0001 | <0.1 | 43 | 4 | 0 | 0 | 47 |
25.4% | 2.4% | 0.0% | 0.0% | |||
0.1 to 1 | 129 | 31 | 0 | 0 | 160 | |
76.3% | 18.3% | 0.0% | 0.0% | |||
1 to 5 | 63 | 38 | 9 | 0 | 110 | |
37.3% | 22.5% | 5.3% | 0.0% | |||
>5 | 7 | 7 | 3 | 0 | 17 | |
4.1% | 4.1% | 1.8% | 0.0% | |||
Total | 242 | 80 | 12 | 0 | 334 | |